Stay updated with breaking news from Multi Dose Vials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MDVs offer economic and logistical advantages for National Immunisation Programmes by minimising packaging and storage expenses, while also reducing medical and environmental waste.
/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL)...
Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.